Access cutting-edge rhabdomyosarcoma treatment through this clinical trial at a research site in Hartford. Study-provided care at no cost to qualified participants.
Access rhabdomyosarcoma specialists in Hartford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rhabdomyosarcoma treatment provided free
This clinical trial will evaluate 4 different strategies of chemotherapy schedules in newly diagnosed participants with metastatic Fusion Positive (alveolar) Rhabdomyosarcoma. The participant and their physician will choose from: Arm A) a first strike therapy, Arm B) a first strike-second strike (maintenance) therapy, Arm C) an adaptively timed therapy, and Arm D) conventional chemotherapy.
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Check if you qualify for this rhabdomyosarcoma clinical trial in Hartford, CT
If you're searching for rhabdomyosarcoma treatment options in Hartford, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hartford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rhabdomyosarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.